Adaptive Biotechnologies ...

NASDAQ: ADPT · Real-Time Price · USD
13.03
0.11 (0.85%)
At close: Aug 15, 2025, 3:59 PM
13.05
0.15%
After-hours: Aug 15, 2025, 07:25 PM EDT

Adaptive Biotechnologies Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Net Income
-121.26M -141.89M -159.59M -195.32M -213.52M -215.11M -225.28M -196.01M -191M -195.27M -200.37M -221.56M -232.24M -229.45M -207.3M -190.51M -171.23M -155.47M
Depreciation & Amortization
18.27M 18.77M 19.26M 20.2M 21.37M 22.02M 22.23M 22.13M 21.75M 21.29M 20.92M 20.48M 18.63M 16.34M 13.95M 11.46M 10.07M 9.16M
Stock-Based Compensation
51.86M 51.46M 53.61M 56.33M 58.15M 62.53M 62.91M 61.65M 60.45M 57.29M 55.48M 53.06M 50.56M 47.63M 43.25M 38.62M 33.45M 28.57M
Other Working Capital
-2.38M -5.56M 4.04M -2.59M -25.75M -30.23M -52.24M -53.29M -63.82M -72.5M -53.36M -61.04M -51.69M -54.87M -59.32M -58.81M -56.17M -46.9M
Other Non-Cash Items
-39.87M -10.08M 7.82M 55.79M 80.04M 57.99M 58.55M 10.74M 9.51M 11.59M 11.29M 11.94M 11.23M 7.86M 6.95M 7.57M 6.85M 5.64M
Deferred Income Tax
n/a n/a n/a -23.79M -26.31M -28.55M -28.55M -4.76M -2.24M n/a n/a 1.28M 3.06M 5.13M 7.23M 7.07M 5.98M 2.43M
Change in Working Capital
10.53M 13.36M 3.05M -3.51M -29.64M -32.01M -46.18M -53.15M -53.88M -73.81M -71.55M -73.23M -60.03M -46.44M -56.82M -52.95M -67.57M -66.67M
Operating Cash Flow
-80.47M -85.34M -95.21M -109.65M -129.27M -135.53M -156.32M -159.41M -155.13M -178.64M -183.94M -207.75M -208.79M -198.94M -192.73M -178.75M -182.46M -176.32M
Capital Expenditures
-2.34M -3.41M -3.66M -4.88M -7.32M -9.28M -10.7M -11.94M -14.6M -16.2M -16.35M -23.05M -32.24M -48.98M -61.75M -61.87M -51.46M -31.68M
Cash Acquisitions
n/a n/a n/a -4.5M -33.42M -74.44M -74.44M 25.07M 53.98M 84.96M 84.96M -10.04M -10.04M n/a n/a n/a n/a n/a
Purchase of Investments
-209.85M -241.43M -244.26M -321.45M -377.28M -393.94M -429.56M -472.6M -382.07M -307.64M -278.78M -192.29M -305.38M -361.44M -316.54M -633.18M -683.57M -602.56M
Sales Maturities Of Investments
268.51M 303.7M 325.71M 385.21M 464.32M 514.4M 569.9M 513.43M 457.43M 352.03M 298.03M 383M 426M 535.5M 559.5M 469M 433M 468.25M
Other Investing Acitivies
n/a 7.61M 53.63M 58.13M 87.05M 120.46M 74.44M -25.07M 9.46M -21.51M 19.25M 190.71M 120.62M 174.06M 242.96M -164.18M -250.57M -134.3M
Investing Cash Flow
56.33M 58.86M 77.79M 58.88M 79.73M 111.18M 129.65M 28.9M 60.77M 28.2M 2.9M 167.66M 88.38M 125.08M 181.21M -226.05M -302.03M -165.98M
Debt Repayment
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Common Stock Repurchased
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
7.23M 5.65M 241K 201K 178K 1.62M 2.25M 2.16M 127.67M 130.19M 132.26M 135.54M 12.94M 15.28M 26.72M 29.69M 30.64M 30.65M
Financial Cash Flow
7.23M 5.65M 241K 201K 178K 1.62M 2.25M 2.16M 127.67M 130.19M 132.26M 135.54M 12.94M 15.28M 27.15M 30.12M 303.23M 303.24M
Net Cash Flow
-13.94M -17.88M -14.22M -47.62M -49.39M -22.74M -24.44M -128.35M 33.3M -20.26M -48.77M 95.45M -107.47M -58.58M 15.63M -374.68M -181.25M -39.06M
Free Cash Flow
-82.81M -88.75M -98.88M -114.53M -136.59M -144.81M -167.02M -171.35M -169.73M -194.84M -200.29M -230.8M -241.03M -247.92M -254.47M -240.62M -233.92M -208M